Nuclear medicine and physics

Composition:

Chair: Lise Borgwardt (Denmark) - Lise.Borgwardt@regionh.dk
Vice chair: Bart de Keizer (The Netherlands) - b.dekeizer@umcutrecht.nl

Members:

  • Bieke Lambert (Belgium)

  • Tereza Kracmerova (Czech Republic)

  • Katerina Taborska (Czech Republic)

  • Anni Morsing (Denmark)

  • Kim Francis (Denmark)

  • Anne Sophie Defachelles (France)

  • Aurore Oudoux (France)

  • Helene Gauthier (France)

  • Holger Amthauer (Germany)

  • Julian Rogash (Germany)

  • Vassiliki Lyra (Greece)

  • Zvi Bar-Sever (Israel)

  • Alice Benigna (Italy)

  • Alice Lorenzoni (Italy)

  • Alice Monaci (Italy)

  • Anna Lisa Martini (Italy)

  • Arnoldo Piccardo (Italy)

  • Bartolomeo Cassano (Italy)

  • Carlo Chiesa (Italy)

  • Catia Olianti (Italy)

  • Gianluca Bottoni (Italy)

  • Giulia Anna Follachio (Italy)

  • Maria Carmen Garganese (Italy)

  • Maria Felicia Villani (Italy)

  • Maria Rita Castellani (Italy)

  • Michaela Allocca (Italy)

  • Milena Pizzoferro (Italy)

  • Paola Saletti (Italy)

  • Vittoria Cannatà (Italy)

  • Jelena Rascon (Lithuania)

  • Renata Komiagiene (Lithuania)

  • Lars Mikalsen (Norway)

  • Anna Sliwinska (Poland)

  • Teresa Ferreira (Portugal)

  • Irene Torres (Spain)

  • Isabel Roca (Spain)

  • Julia Balaguer (Spain)

  • Pablo Minguez (Spain)

  • Raquel Sanchez (Spain)

  • Stephan Prado (Spain)

  • Laure Michaud (Switzerland)

  • Nedim Gulaldi (Turkey)

  • Glenn Flux (United Kingdom)

  • Hugh Wallace (United Kingdom)

  • Karolina Switaj (United Kingdom)

  • Matthey Aldrige (United Kingdom)

  • Michael Bradnam (United Kingdom)

  • Ming Wan (United Kingdom)

  • Sarah Kelly (United Kingdom)

  • Simon Wan (United Kingdom)


Aims

Specific deliverable objective(s) for next 1 year:

  • SIOPEN Scoring definition. Comparison of different evaluation among Nuc-Med members as already assessed.  Producing GL to score with high inter-observer reproducibility.

  • Scoring a MIBG data set in a selected cohort of patients with RTqPCR mRNA vs mIBG study in HR-NB1.

  • Anti-GD2-PET tracer in induction and maintenance therapy.

  • Review of literature on T CD8-positive cells with 89Zr-PET tracer during immunotherapy and immunoresponse.

Objectives for the next 5 years:

  • Research and publications about the above-listed researches.

  • Chair and the co-chair election allowing young members to take these positions in October 2024 end of them.

Key achievements

  • Position paper on imaging of HR-NB and NUCMed/Physics work group with Radiology Committee

  • Co-working with QoL – LTO and BIOPORTAL for  eCRF collaborative work

  • mRT-qPCR Committee for a comparison with MIBG Scoring values.

  • Consultings (n°2  in HR-NB 123I-mIBG)

  • Metabolic radiotherapy and dosimetry meaning in children with pheochromocytoma/paraganglioma/ganglioneuroma/neuroblastoma

  • 3D radiological/nuclear medicine merged imaging in the presurgical evaluation and post-surgical assessment of residual tumor.

Selected outputs

  1. EANM’20 Virtual - Presentation ID EP-224 : Simplify scoring System vs SIOPEN in prognosis risk assessment in Neuroblastoma. C. Olianti1, M. Allocca2, A. Martini2, A. Tondo3, H. Gauthier4. B91 Paediatric Study.

  2. EANM’20 Virtual - OP 346 : SIOPEN SCORING vs 3 Simplified Scoring Systems in Pediatric Patients with HR-NB-1 and L2-NB. C. Olianti, A. Martini, R. Di Dato, M. Allocca, A. Tondo, H. Gauthier. B91 Paediatric Study.

  3. EANM’20 Virtual - EP-362 - Tandem High-Dose 131I-MIBG Therapy For Paediatric Patients With Relapsed-Refractory High Risk Neuroblastoma: A Dosimetry Based Treatment . C. Altini, M. Villani, B. Cassano, M. Pizzoferro, A. Serra, A. Castellano, V. Cannatà, M. Garganese.

  4. EANM’20 Virtual - A correlation study between clinical outcome and absorbed dose to organs at risk and lesions for patients with High-Risk Neuroblastoma administered with highactivity therapy of 131I-mIBG. B. Cassano, M. Pizzoferro, S. Valeri, S. Donatiello, C. Polito, D. Ciucci, F. Martire A. Castellano, C. Altini, M. C. Garganese V. Cannatà.

  5. EANM’20 Virtual - OP-428 Calibration, radioprotection and dosimetry in Lu-177 treatment of Neuro Endocrine tumours. P. Saletti, S. Raspanti, A. D’Agata, F. Rossi, M. Papi, G. Belli.

  6. EANM’20 Virtual - EPS-040 Gamma Camera Calibration to Perform SPECT/CT-based Dosimetry in 177Lu-DOTATATE Treatments. T. Monserrat Fuertes, N. Montenegro Iglesias, D. Álvarez S104Llorente, M. Peinado Montes, D. San José Olmedo, P. Mínguez.

  7. EANM’20 Virtual - OP-902. Printing 3D Heterogeneous Activity Distributions for Quality Control of SPECT and PET. J. Gear, G. Flux.

  8. EANM’20 Virtual - OP-180. Initial experience with 177lutetium peptide receptor radionuclide therapy for pediatric patients with somatostatin-receptor-positive tumors
    M. Pizzoferro, B. Cassano, C. Altini, A. Serra, M. Cefalo, A. Cacchione, M. Villani, A. Castellano, V. Cannatà, M. Garganese.


Interested in joining the Specialty committee?

Please first register to become a SIOPEN member and then contact the specialty committee chair and/or co-chair in order to join the committee.

Previous
Previous

New Drug Development

Next
Next

Pathology